INS and neoplasm: Second, metformin can also reduce the activation of insulin/IGF-1 (insulin-like growth factor 1) receptors in tumor cells, resulting in reduced stimulation of the mitogenic pathway, thereby indirectly inhibiting cell proliferation, tumor formation and metastasis24,25.